Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Curious about which cards offer the best rewards? Explore options that provide maximum benefits for your spending habits.
23,678 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Forward Industries jumped after confirming it expanded its SOL holdings by more than 500,000 coins. Here’s what this ...
Bitcoin steadies near key levels as risk appetite returns amid mixed geopolitical headlines. This guide breaks down t...
A broad rally in nuclear stocks helped Constellation Energy ride the wave. This piece breaks down the catalysts, what...
A notable hedge fund just put $20 million into BlackLine. Is this the spark a turnaround scenario needs, or a cautiou...
A Roth conversion before retirement offers more than tax-free withdrawals. It can act as a tax hedge, increase flexib...
One staffing stock plunged 56% in the last year, but a large new stake worth almost $10 million could signal a forthc...
As Reynolds prepares to report its 2026 earnings, investors are weighing growth catalysts, margin resilience, and pot...
Nvidia’s quarterly print arrives amid an AI demand cycle that remains uneven. Analysts say nvidia earnings don’t matt...
Investing in memory chips means weighing volatility against opportunity. This article digs into could micron technolo...
Usio's Q4 2025 earnings reveal a business building momentum in payments services. This analysis breaks down the numbe...
Regulators warn of a loophole that allows new chemicals to enter foods and supplements without premarket approval. Th...